Cephalexin is the first oral first-generation cephalosporin to enter widespread clinical use, effective against Gram-positive pathogens for skin, soft-tissue and urinary tract infections. Simson Pharma's Cephalexin reference standard and impurities support the high-volume compendial testing this long-established generic antibiotic demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cephalexin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.